Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors

NCT00515216 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Stomach Neoplasms
Esophageal Neoplasms

Interventions

DRUG: 5-fluorouracil
DRUG: Oxaliplatin
DRUG: Leucovorin

Sponsor

Vanderbilt University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]